Disposition of 2,2′,4,4′,5,5′-hexabromodiphenyl ether (BDE153) and its interaction with other polybrominated diphenyl ethers (PBDEs) in rodents

Xenobiotica

Volumn 36, Issue 9, 2006, Pages 824-837

  Sanders, J M ^a,b   Lebetkin, E H ^a   Chen, L J ^a   Burka, L T ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Metabolism and disposition; Persistent organic pollutants; Polybrominated diphenyl ethers (PBDEs)

Indexed keywords

2,2',4,4' TETRABROMODIPHENYLETHER; 2,2',4,4',5 PENTABROMODIPHENYLETHER; 2,2',4,4',5,5' HEXABROMODIPHENYLETHER; BDE 153; BDE 47; BDE 99; CARBON 14; ETHER DERIVATIVE; POLYBROMINATED DIPHENYL ETHER; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; FEMALE; FIRST PASS EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; RAT;

ANIMALS; CARBON RADIOISOTOPES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FECES; FEMALE; HALOGENATED DIPHENYL ETHERS; MALE; MICE; PHENYL ETHERS; POLYBROMINATED BIPHENYLS; RADIOACTIVITY; RATS; RATS, INBRED F344;

RODENTIA;

EID: 33748677676     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.1080/00498250600815906     Document Type: Article

References (20)

1. 2U-globulins and aphrodisin. Biochimica et Biophysica Acta 1482:218-228.
2. Chen L-G, Mai B-X, Bi X-H, Chen S-J, Wang X-M, Ran Y, Luo X-J, Sheng G-Y, Fu J-M, Zeng EY. 2006a. Concentration levels, compositional profiles, and gas-particle partitioning of polybrominated diphenyl ethers in the atmosphere of an urban city in south China. Environmental Science and Technology 40:1190-1196.
3. Chen L-J, Lebetkin EH, Sanders JM, Burka LT. 2006b. Metabolism and disposition of 2,2′,4,4′,5-pentabromodiphenyl ether (BDE99) following single or repeated administration to rats and mice. Xenobiotica 36:515-534.
4. De Wit CA. 2002. An overview of brominated flame retardants in the environment. Chemosphere 46:583-624.
5. Fowles JR, Fairbrother A, Baecher-Steppan L, Kerkvliet NI. 1994. Immunologic and endocrine effects of the flame-retardant pentabromodiphenyl ether (DE71) in C57BL/6J mice. Toxicology 86:49-61.
6. Hardy ML. 2004. A comparison of the fish bioconcentration factors for brominate flame retardants with their nonbrominated analogues. Environmental Toxicology and Chemistry 23:656-661.
7. Hites RA. 2004. Polybrominated diphenyl ethers in the environment and in people: A meta-analysis of concentrations. Environmental Science and Technology 38:945-956.
8. Lyche JL, Skaare JU, Larsen HJS, Ropstad E. 2004. Levels of PCB 126 and PCB 153 in plasma and tissues in goats exposed during gestation and lactation. Chemosphere 55:621-629.
9. Matthews HB, Dedrick RL. 1984. Pharmacokinetics of PCBs. Annual Review of Pharmacology and Toxicology 24:85-103.
10. McClain RM. 1995. Mechanistic considerations for the relevance of animal data on thyroid neoplasia to human risk assessment. Mutation Research 333:131-142.
11. McDonald TA. 2005. Polybrominated diphenyl ether levels among United States residents: Daily intake and risk of harm to the developing brain and reproductive organs. Integrated Environmental Assessment and Management 1:343-354.
12. Meerts IATM, Van Zanden JJ, Luijks EAC, Van Leeuwen-Bol I, Marsh G, Jakobsson E, Bergman Å, Brouwer A. 2000. Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro. Toxicological Sciences 56:95-104.
13. Meironyté D, Norén K, Bergman Å. 1999. Analysis of polybrominated diphenyl ethers in Swedish human milk. A time-related trend study, 1972-1997. Journal of Toxicology and Environmental Health, Part A 58:329-341.
14. Sanders JM, Burka LT, Smith CS, Black W, James R, Cunningham ML. 2005. Differential expression of CYP1A, 2B, and 3A genes in the F344 rat following exposure to a polybrominated diphenyl ether mixture or individual components. Toxicological Sciences 88:127-133.
15. Sanders JM, Chen L-J, Lebetkin EH, Burka LT. 2006. Metabolism and disposition of 2,2′,4,4′-tetrabromodiphenyl ether following administration of single or multiple doses to rats and mice. Xenobiotica 36:103-117.
16. Sjödin A, Jakobsson E, Kierkegaard A, Marsh G, Sellström U. 1998. Gas chromatographic identification and quantification of polybrominated diphenyl ethers in a commercial product, Bromkal 70-5DE. Journal of Chromatography 822:83-89.
17. Sjödin A, Jones RS, Focant J-F, Lapeza C, Wang RY, McGahee EE, Zhang Y, Turner WE, Slazyk B, Needham LL, Patterson DG. 2004. Retrospective time-trend study of polybrominated diphenyl ether and polybrominated and polychlorinated biphenyl levels in human serum from the United States. Environmental Health Perspectives 112:654-658.
18. Von Meyerinck L, Hufnagel B, Schmoldt A, Benthe HF. 1990. Induction of rat liver microsomal cytochrome P-450 by the pentabromo diphenyl ether Bromkal 70 and half-lives of its components in the adipose tissue. Toxicology 61:259-274.
19. Zhou T, Ross DG, De Vito MJ, Crofton KM. 2001. Effects of short-term in vivo exposure to polybrominated diphenyl ethers on thyroid hormones and hepatic enzyme activities in weanling rats. Toxicological Sciences 61:76-82.
20. Zhou T, Taylor MM, De Vito MJ, Crofton KM. 2002. Developmental exposure to brominated diphenyl ethers results in thyroid hormone disruption. Toxicological Sciences 66:105-116.